Derivation data set | Validation data set | |
Number of CXR available for report | ||
Baseline | 112 | 136 |
2 months | 76 | 93 |
6 months | 76 | 76* |
Baseline radiological findings | ||
Consolidation, n (%) | 106 (94.6) | 104 (76.5) |
Cavitation, n (%) | 71 (63.4) | 77 (56.6) |
Effusion, n (%) | 37 (33.0) | 24 (17.3) |
Miliary, n (%) | 2 (1.7) | 5 (3.7) |
Nodules, n (%) | 83 (72.2) | 29 (21.3) |
Fibrosis, n (%) | 62 (55.3) | 10 (7.4) |
Proportion of lung affected, median % (range) | 35 (0–100) | 41.5 (0–100) |
CXR weighted score characteristics | ||
Baseline score, median (range) | 65 (5–130) | 69 (0–140) |
2 month score, median (range) | 35 (0–130) | 29 (0–140) |
6 month score, median (range) | 10 (0–105) | 10 (0–115) |
Median score decrease in 2 months, % | 27.3 | 38.8 |
Median score decrease in 6 months, % | 73.1 | 80.2 |
Baseline score by smear grade at diagnosis median (range) | ||
0 | 15 (0.5–70) | 10 (0–133) |
Scanty or 1+ | 50 (0–110) | 66 (0–140) |
2+ | 70 (6.5–135) | 76 (11–140) |
3+ | 80 (10–140) | 85 (4–140) |
↵* 30 patients still under follow up.